Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Oncology Institute of Southern Switzerland
National Institutes of Health Clinical Center (CC)
Kansas State University
National Institutes of Health Clinical Center (CC)
The Netherlands Cancer Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Abramson Cancer Center at Penn Medicine
Sirnak State Hospital
University Medical Center Groningen
Istanbul University
Heinrich-Heine University, Duesseldorf
M.D. Anderson Cancer Center